Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006617
Status:
COMPLETED
Last Update Posted:
2015-05-15
First Post:
2000-12-06
Brief Title:
Four-Drug Combination Therapy With Zidovudine Lamivudine 1592U89 Abacavir and 141W94 Amprenavir in HIV-Infected Patients
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Conditions & Keywords Data
Conditions:
| Name |
|---|
| HIV Infections |
Keywords:
| Name | View |
|---|---|
| abacavir | View |
| HIV-1 | View |
| Drug Therapy Combination | View |
| Zidovudine | View |
| Lymphoid Tissue | View |
| Gastrointestinal System | View |
| HIV Protease Inhibitors | View |
| Lamivudine | View |
| Lymphocyte Subsets | View |
| VX 478 | View |
| Reverse Transcriptase Inhibitors | View |
| Anti-HIV Agents | View |
| Viral Load | View |
| Cerebrospinal Fluid | View |